OSAnalyzer: A Bioinformatics Tool for the Analysis of Gene Polymorphisms Enriched with Clinical Outcomes

Background: The identification of biomarkers for the estimation of cancer patients’ survival is a crucial problem in modern oncology. Recently, the Affymetrix DMET (Drug Metabolizing Enzymes and Transporters) microarray platform has offered the possibility to determine the ADME (absorption, distribu...

Descripción completa

Detalles Bibliográficos
Autores principales: Agapito, Giuseppe, Botta, Cirino, Guzzi, Pietro Hiram, Arbitrio, Mariamena, Di Martino, Maria Teresa, Tassone, Pierfrancesco, Tagliaferri, Pierosandro, Cannataro, Mario
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5197943/
https://www.ncbi.nlm.nih.gov/pubmed/27669316
http://dx.doi.org/10.3390/microarrays5040024

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5197943/
https://www.ncbi.nlm.nih.gov/pubmed/27669316
http://dx.doi.org/10.3390/microarrays5040024

Ejemplares similares